Upcoming Webinar: Rooted in Excellence—Evolving Strategies in Aortic Surgery

Join our webinar exploring complex aortic root procedures, with expert panelists sharing insights, techniques, and evidence-based strategies for treating these challenging cases. Learn how the KONECT RESILIA® aortic valved conduit is streamlining bio-Bentall procedures and how RESILIA® tissue demonstrates clinically stable hemodynamic performance and potential longer valve durability.

Live on Tuesday, October 14 - 4:00 PM PT / 7:00 PM ET

Register Here!

SPEAKERS

Ibrahim Sultan, MD
Professor and Chief, Division of Cardiac Surgery
Executive Vice Chair, Department of Cardiothoracic Surgery
Co-Director, UPMC Heart and Vascular Institute
University of Pittsburgh Medical Center
                                  Pittsburgh, Pennsylvania

Malakh Shrestha, MBBS, Ph.D.
Director, Mayo Clinic Aortic Center
Director, Aortic Surgery
Professor of Surgery, Mayo College of Medicine & Science
The Mayo Clinic
                                  Rochester, Minnesota

Patrick Vargo, MD
Staff Surgeon, Thoracic and Cardiovascular Surgery
Cleveland Clinic
Cleveland, Ohio
 

Tsuyoshi Kaneko, MD
John M. Shoenberg Chair in Cardiovascular Disease
Chief, Section of Cardiac Surgery
Professor of Surgery, Division of Cardiothoracic Surgery
Washington University
                                  St. Louis, Missouri

Register Now

Important Safety Information: KONECT RESILIA Aortic Valved Conduit Indications: For use in replacement of native or prosthetic aortic heart valves and the associated repair or replacement of a damaged or diseased ascending aorta. Contraindications: There are no known contraindications with the use of the KONECT RESILIA aortic valved conduit. Complications and Side Effects: Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, any of which could lead to reoperation, explantation, permanent disability, and death. Adverse events potentially associated with the use of polyester vascular grafts include hemorrhage, thrombosis, graft infection, embolism, aneurysm, pseudoaneurysm, seroma, occlusion (anastomotic intimal hyperplasia), immunological reaction to collagen (shown to be a weak immunogen; infrequent, mild, localized and self-limiting), intimal peel formation, and conduit dilatation, any of which could lead to re-operation, explantation, permanent disability, and death.
CAUTION: US law restricts these devices to sale by or on the order of a physician. See instructions for use for full prescribing information.
Reference:
1. Kaneko, T, Johnston D, Bavaria JE, et al. Propensity-matched 8-year Outcomes Following Surgical Aortic Valve Replacement With Novel Calcification-resistant Versus Contemporary Tissue Bioprostheses. Presentation presented at: the Heart Valve Society Annual Scientific Meeting, 2025; Cairo, Egypt. Abstract available at: https://heartvalvesociety.org/meeting/program/2025/AC22.cgi
As a member of the Advanced Medical Technology Association (“AdvaMed”), Edwards strictly adheres to the requirements of the AdvaMed Code of Ethics on Interactions with Health Care Professionals. This course does not provide CME credit. Participant spouses or guests may not attend, and no items or benefits will be provided to them. Speakers, instructors, moderators and/or panelists may receive compensation and reimbursement of reasonable travel expenses from Edwards for their services in compliance with applicable laws and the AdvaMed Code of
Ethics. If required by law (e.g., US Sunshine Law), Edwards will disclose the value of any meals, travel and/or educational items provided to health care professionals attending this program, and Edwards also may publish such information on its website or other public manner in order to provide the public with full disclosure of its financial arrangements with health care professionals.
The value of any food or refreshments provided by Edwards at this meeting will be apportioned among all attendees. If you expressly decline to partake of any offered food or refreshments, or desire to personally pay for such food or refreshments, please let your Edwards representative know.
All speakers are paid consultants for Edwards Lifesciences. Edwards, Edwards Lifesciences, the stylized E logo, KONECT, KONECT RESILIA, and RESILIA are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.
© 2025 Edwards Lifesciences Corporation. All rights reserved. PP--US-11585 v1.0 Edwards Lifesciences • One Edwards Way, Irvine CA 92614 USA • edwards.com

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.